AMORCYTE MYOCARDIAL REPAIR STUDY- A Phase I Trial of Intra-Coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction. (AMRS).

Trial Profile

AMORCYTE MYOCARDIAL REPAIR STUDY- A Phase I Trial of Intra-Coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction. (AMRS).

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Nov 2013

At a glance

  • Drugs NBS 10 (Primary)
  • Indications Myocardial infarction
  • Focus Adverse reactions
  • Acronyms AMRS
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 02 Feb 2010 Planned end date (Mar 2012) added as reported by ClinicalTrials.gov.
    • 30 Mar 2009 Results presented at the American College of Cardiology Annual Scientific Session, as reported by Amorcyte.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top